Literature DB >> 35066634

Perfusion measurement in brain gliomas using velocity-selective arterial spin labeling: comparison with pseudo-continuous arterial spin labeling and dynamic susceptibility contrast MRI.

Yaoming Qu1, Dexia Kong1, Haitao Wen1, Xiaochan Ou1, Qihong Rui1, Xianlong Wang1, Doris D Lin2, Qin Qin2,3, Zhibo Wen4.   

Abstract

OBJECTIVES: To evaluate the performance of velocity-selective (VS) ASL among patients with untreated gliomas by comparing with both pseudo-continuous (PC) ASL and dynamic susceptibility contrast-enhanced perfusion-weighted imaging (DSC-PWI).
METHODS: Forty-four consecutive patients with newly diagnosed glioma who underwent preoperative perfusion MRI including VSASL, PCASL, and DSC-PWI between 2017 and 2019 were retrospectively evaluated. Visual inspection was performed to evaluate the tumor signal intensity relative to gray matter based on 1-5 score criteria and weighted kappa was used to evaluate the pair-wise concordance between VSASL or PCASL and DSC-PWI. The relative tumor blood flow (rTBF) was measured from sampling intra-tumoral areas of hot-spot on the blood flow map and normalized against the contralateral normal gray matter blood flow. Linear regression and Bland-Altman analyses were performed to evaluate the correlation and agreement of rTBF measurements between ASL methods and DSC-PWI. The ROC analysis was constructed to determine the diagnostic performance of three perfusion methods for grading gliomas.
RESULTS: TBF maps derived from VSASL were more comparable with DSC-PWI than PCASL on visual inspection (weighted kappa of 0.90 vs 0.68). In quantitative analysis, VSASL-rTBF yielded higher correlation with the values from DSC-PWI than PCASL-rTBF (R2 = 80% vs 47%, p < 0.001 for both). Both ASL and DSC-derived rTBF showed good distinction between low-grade and high-grade gliomas (p < 0.001). Compared to PCASL, VSASL yielded superior diagnostic sensitivity, specificity, and accuracy in glioma grading.
CONCLUSIONS: VSASL showed great promise for accurate quantification of TBF and could potentially improve the diagnostic performance of ASL in preoperative grading of gliomas. KEY POINTS: • VSASL demonstrated a greater agreement with DSC-PWI than with PCASL on visual inspection and perfusion quantification. • VSASL showed a higher diagnostic sensitivity, negative predictive value, and accuracy than PCASL for glioma grading. • With the advantages of insensitivity to transit delay and no need of prescribing a labeling plane, VSASL could potentially improve the diagnostic performance of ASL for a more accurate, noninvasive quantification of TBF in patients with glioma.
© 2021. The Author(s), under exclusive licence to European Society of Radiology.

Entities:  

Keywords:  Diagnosis, Differential; Glioma; Magnetic resonance imaging; Perfusion imaging

Mesh:

Substances:

Year:  2022        PMID: 35066634     DOI: 10.1007/s00330-021-08406-7

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  56 in total

1.  Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.

Authors:  Carsten Warmuth; Matthias Gunther; Claus Zimmer
Journal:  Radiology       Date:  2003-06-20       Impact factor: 11.105

2.  Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors.

Authors:  Eric S Paulson; Kathleen M Schmainda
Journal:  Radiology       Date:  2008-09-09       Impact factor: 11.105

Review 3.  Primary brain tumours in adults.

Authors:  Sarah Lapointe; Arie Perry; Nicholas A Butowski
Journal:  Lancet       Date:  2018-07-27       Impact factor: 79.321

Review 4.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

5.  CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014.

Authors:  Quinn T Ostrom; Haley Gittleman; Peter Liao; Toni Vecchione-Koval; Yingli Wolinsky; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2017-11-06       Impact factor: 12.300

Review 6.  A meta-analysis of arterial spin labelling perfusion values for the prediction of glioma grade.

Authors:  L Kong; H Chen; Y Yang; L Chen
Journal:  Clin Radiol       Date:  2016-12-06       Impact factor: 2.350

7.  Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging.

Authors:  Soonmee Cha; Tarik Tihan; Forrest Crawford; Nancy J Fischbein; Susan Chang; Andrew Bollen; Sarah J Nelson; Michael Prados; Mitchel S Berger; William P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

8.  Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

Authors:  Meng Law; Robert J Young; James S Babb; Nicole Peccerelli; Sophie Chheang; Michael L Gruber; Douglas C Miller; John G Golfinos; David Zagzag; Glyn Johnson
Journal:  Radiology       Date:  2008-03-18       Impact factor: 11.105

Review 9.  Angiogenesis in brain tumours.

Authors:  Rakesh K Jain; Emmanuelle di Tomaso; Dan G Duda; Jay S Loeffler; A Gregory Sorensen; Tracy T Batchelor
Journal:  Nat Rev Neurosci       Date:  2007-08       Impact factor: 34.870

10.  Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields.

Authors:  Weiying Dai; Dairon Garcia; Cedric de Bazelaire; David C Alsop
Journal:  Magn Reson Med       Date:  2008-12       Impact factor: 4.668

View more
  1 in total

Review 1.  Velocity-selective arterial spin labeling perfusion MRI: A review of the state of the art and recommendations for clinical implementation.

Authors:  Qin Qin; David C Alsop; Divya S Bolar; Luis Hernandez-Garcia; James Meakin; Dapeng Liu; Krishna S Nayak; Sophie Schmid; Matthias J P van Osch; Eric C Wong; Joseph G Woods; Greg Zaharchuk; Moss Y Zhao; Zungho Zun; Jia Guo
Journal:  Magn Reson Med       Date:  2022-07-12       Impact factor: 3.737

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.